These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 19765801)
21. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients. Jiang YX; Li PA; Yang SW; Hao YX; Yu PW Int J Clin Exp Pathol; 2015; 8(6):7002-8. PubMed ID: 26261590 [TBL] [Abstract][Full Text] [Related]
22. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Pelloski CE; Lin E; Zhang L; Yung WK; Colman H; Liu JL; Woo SY; Heimberger AB; Suki D; Prados M; Chang S; Barker FG; Fuller GN; Aldape KD Clin Cancer Res; 2006 Jul; 12(13):3935-41. PubMed ID: 16818690 [TBL] [Abstract][Full Text] [Related]
23. [The importance of determining the prognostic marker YKL-40 in serum and tissues]. Łata E; Gisterek I; Matkowski R; Szelachowska J; Kornafel J Pol Merkur Lekarski; 2010 Jun; 28(168):505-8. PubMed ID: 20642115 [TBL] [Abstract][Full Text] [Related]
24. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of YKL-40 Predicts Poor Prognosis in Patients Undergoing Curative Resection of Pancreatic Cancer. Chen HT; Zheng JM; Zhang YZ; Yang M; Wang YL; Man XH; Chen Y; Cai QC; Li ZS Pancreas; 2017 Mar; 46(3):323-334. PubMed ID: 28099248 [TBL] [Abstract][Full Text] [Related]
26. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer. Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752 [TBL] [Abstract][Full Text] [Related]
27. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Thöm I; Andritzky B; Schuch G; Burkholder I; Edler L; Johansen JS; Bokemeyer C; Schumacher U; Laack E Cancer; 2010 Sep; 116(17):4114-21. PubMed ID: 20564116 [TBL] [Abstract][Full Text] [Related]
28. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer. Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416 [TBL] [Abstract][Full Text] [Related]
29. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis. Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703 [TBL] [Abstract][Full Text] [Related]
30. Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast. Roslind A; Balslev E; Kruse H; Staergaard B; Horn T Ultrastruct Pathol; 2008; 32(3):101-6. PubMed ID: 18570155 [TBL] [Abstract][Full Text] [Related]
31. Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma. Schmidt H; Johansen JS; Sjoegren P; Christensen IJ; Sorensen BS; Fode K; Larsen J; von der Maase H J Clin Oncol; 2006 Feb; 24(5):798-804. PubMed ID: 16391295 [TBL] [Abstract][Full Text] [Related]
32. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
33. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients. Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238 [TBL] [Abstract][Full Text] [Related]
34. New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma. Liu F; Shen D; Kang X; Zhang C; Song Q J Clin Pathol; 2015 Nov; 68(11):913-6. PubMed ID: 26157147 [TBL] [Abstract][Full Text] [Related]
35. High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients. Zhang X; Xu S; Tan Q; Liu L Cancer Epidemiol; 2013 Dec; 37(6):1010-3. PubMed ID: 24139593 [TBL] [Abstract][Full Text] [Related]
36. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825 [TBL] [Abstract][Full Text] [Related]
37. YKL-40 expression could be a poor prognostic marker in the breast cancer tissue. Kang EJ; Jung H; Woo OH; Park KH; Woo SU; Yang DS; Kim AR; Lee JB; Kim YH; Kim JS; Seo JH Tumour Biol; 2014 Jan; 35(1):277-86. PubMed ID: 23918300 [TBL] [Abstract][Full Text] [Related]
38. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis. Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473 [TBL] [Abstract][Full Text] [Related]
39. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231 [TBL] [Abstract][Full Text] [Related]
40. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]